DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

321.65 -1.20 (-0.37%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IBB $321.65 -0.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $323.93
Previous Close $322.85
Daily Range $321.06 - $329.16
52-Week Range $207.48 - $329.20
Market Cap $7.4B
P/E Ratio -1,403.70
Dividend (Yield) $0.22 (0.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,688,555
Average Daily Volume 1,567,608
Current FY EPS $0.00




Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website:

News & Commentary

Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.

Costly new drugs have driven pharma stock prices to all-time highs over the last two years. Here's why this trend might come to a screeching halt.

A Time To Cheer Or A Time To Cry

IBB Is +34% For 1 Year And +7.31% For 2015 - But What Are The Risks?

March 13th Options Now Available For iShares Nasdaq Biotechnology Index Fund (IBB)

IShares Nasdaq Biotechnology ETF Experiences Big Outflow

Will You Miss The Netflix Ride To $1,000?

Tech ETF IBB Brings Plenty Of Risk But It Fits Nicely In A Portfolio

With The Fed Fading Into The Shadows, Investors Look Overseas For New Catalysts

A New Biotech ETF Looks To Bring The Genomic Revolution To Investors

Will Mario Draghi Put A Floor Under Oil?

Gilead: A Bullish Update

See More IBB News...

IBB's Top Competitors

IBB $321.65 (-0.37%)
Current stock: IBB
VTA $11.70 (-0.43%)
Current stock: VTA
NCV $8.94 (-0.33%)
Current stock: NCV
ZTR $13.75 (-0.07%)
Current stock: ZTR